8 results on '"Benoit, J."'
Search Results
2. Impact of Lifestyle Medicine Interventions on the Management of Systemic Hypertension in Primary Care: A Canadian Randomized Controlled Trial.
- Author
-
Marin-Couture, Elisa, Moulin, Julie-Alexandra, Thibault, Anne-Sophie, Poirier, Paul, Després, Jean-Pierre, Gallant, Anette, Lamarre, Vincent, Alméras, Natalie, Lemieux, Isabelle, Chabot, Christian, Gallani, Maria-Cecilia, Piché, Marie-Eve, Arsenault, Benoit J., Tremblay, Angelo, Paquette, Jean-Sébastien, and Rhéaume, Caroline
- Subjects
LIFESTYLES ,CONTINUING education units ,MEDICAL protocols ,RESEARCH funding ,ADIPOSE tissues ,HEALTH status indicators ,ACADEMIC medical centers ,BLOOD testing ,PRIMARY health care ,HYPERTENSION ,EDUCATIONAL outcomes ,BODY composition ,STATISTICAL sampling ,COMPUTED tomography ,ANTIHYPERTENSIVE agents ,TREATMENT effectiveness ,RANDOMIZED controlled trials ,CARDIOVASCULAR diseases risk factors ,DESCRIPTIVE statistics ,DASH diet ,CARDIOPULMONARY system ,COUNSELING ,ANTHROPOMETRY ,EXERCISE tests ,OXYGEN consumption ,DATA analysis software ,BLOOD pressure measurement ,PHYSICAL activity ,EVALUATION - Abstract
The study aimed to evaluate the feasibility of implementing lifestyle interventions in primary care settings with hypertensive patients and their effect on blood pressure, body composition, cardiometabolic markers, and antihypertensive drug use. Sixty participants diagnosed with stage 1 hypertension were randomly assigned to 4 groups: (1) Standard medical care (control), (2) Physical activity protocol, (3) Dietary Approach to Stop Hypertension (DASH) diet, and (4) Combination of physical activity protocol and DASH diet. Participants received counseling from family physicians, nurses, kinesiologists, and registered dietitians. Various assessments were conducted before (T0) and after (T6) the interventions, including 24-h ambulatory blood pressure monitoring, blood and urine tests, anthropometric measurements, computed tomography to measure adipose tissue, submaximal exercise test to estimate maximal oxygen consumption and health questionnaires. Fifty-one (51) participants (51/57, 89%) completed the program. All interventions reduced blood pressure indices between T
0 and T6 , except the combined interventions group. Body composition and cardiometabolic parameters were improved in all groups, except for the control group. In total, 28% of participants (7/23) reduced or stopped their antihypertensive medications at T6 . The results suggest that structured lifestyle interventions are feasible in primary care and improve blood pressure and cardiometabolic parameters in patients with stage 1 hypertension. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
3. Polygenic inheritance and its interplay with smoking history in predicting lung cancer diagnosis: a French-Canadian case-control cohort.
- Author
-
Boumtje V, Manikpurage HD, Li Z, Gaudreault N, Armero VS, Boudreau DK, Renaut S, Henry C, Racine C, Eslami A, Bougeard S, Vigneau E, Morissette M, Arsenault BJ, Labbé C, Laliberté AS, Martel S, Maltais F, Couture C, Desmeules P, Mathieu P, Thériault S, Joubert P, and Bossé Y
- Subjects
- Humans, Case-Control Studies, Female, Male, Middle Aged, Aged, Risk Factors, Canada epidemiology, Polymorphism, Single Nucleotide, France epidemiology, Lung Neoplasms genetics, Lung Neoplasms diagnosis, Lung Neoplasms epidemiology, Lung Neoplasms etiology, Multifactorial Inheritance, Smoking adverse effects, Smoking epidemiology, Genetic Predisposition to Disease, Genome-Wide Association Study
- Abstract
Background: The most near-term clinical application of genome-wide association studies in lung cancer is a polygenic risk score (PRS)., Methods: A case-control dataset was generated consisting of 4002 lung cancer cases from the LORD project and 20,010 ethnically matched controls from CARTaGENE. A genome-wide PRS including >1.1 million genetic variants was derived and validated in UK Biobank (n = 5419 lung cancer cases). The predictive ability and diagnostic discrimination performance of the PRS was tested in LORD/CARTaGENE and benchmarked against previous PRSs from the literature. Stratified analyses were performed by smoking status and genetic risk groups defined as low (<20th percentile), intermediate (20-80th percentile) and high (>80th percentile) PRS., Findings: The phenotypic variance explained and the effect size of the genome-wide PRS numerically outperformed previous PRSs. Individuals with high genetic risk had a 2-fold odds of lung cancer compared to low genetic risk. The PRS was an independent predictor of lung cancer beyond conventional clinical risk factors, but its diagnostic discrimination performance was incremental in an integrated risk model. Smoking increased the odds of lung cancer by 7.7-fold in low genetic risk and by 11.3-fold in high genetic risk. Smoking with high genetic risk was associated with a 17-fold increase in the odds of lung cancer compared to individuals who never smoked and with low genetic risk., Interpretation: Individuals at low genetic risk are not protected against the smoking-related risk of lung cancer. The joint multiplicative effect of PRS and smoking increases the odds of lung cancer by nearly 20-fold., Funding: This work was supported by the CQDM and the IUCPQ Foundation owing to a generous donation from Mr. Normand Lord., Competing Interests: Declaration of interests B. Arsenault received research grants from Silence Therapeutics, Pfizer and Eli Lilly; received consulting fees from Silence Therapeutics, Novartis, Eli Lilly and Editas Medicine. C. Labbé received consulting fees from Amgen, AstraZeneca, Bristol-Myers-Squibb, EMD Serono, Jazz Pharmaceuticals, LEO Pharma, Lilly, Merck, Pfizer, Roche and Sanofi Genzyme. S. Martel received research grants the Ministry of Health province of Quebec and Canadian Partnership Against Cancer. Y. Bossé has received research grants from the IUCPQ Foundation. The remaining authors declare no conflict of interest., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Fertility preservation in patients undergoing gonadotoxic treatments: a Canadian Fertility and Andrology Society clinical practice guideline.
- Author
-
Roberts JE, Benoit J, Foong S, Saumet J, Korkidakis A, Marr K, McQuillan S, and Todd N
- Subjects
- Humans, Canada, Female, Male, Andrology, Antineoplastic Agents adverse effects, Fertility Preservation methods, Cryopreservation, Neoplasms therapy
- Abstract
The management of young patients with cancer presents several unique challenges. In general, these patients are ill prepared for the diagnosis and the impact on their fertility. With the improved survival for all tumour types and stages, the need for adequate fertility counselling and a multidisciplinary approach in the reproductive care of these patients is paramount. Recent advances in cryopreservation techniques allow for the banking of spermatozoa, oocytes, embryos and ovarian tissue without compromising survival. This Canadian Fertility and Andrology Society (CFAS) guideline outlines the current understanding of social and medical issues associated with oncofertility, and the medical and surgical technologies available to optimize future fertility., (Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. Characteristics of Acute Childhood Illness Apps for Parents: Environmental Scan.
- Author
-
Benoit J, Hartling L, Chan M, and Scott S
- Subjects
- Canada, Child, Delivery of Health Care, Health Behavior, Humans, Parents, Mobile Applications
- Abstract
Background: Providing parents with resources that aid in the identification and management of acute childhood illnesses helps those parents feel better equipped to assess their children's health and significantly changes parental health-seeking behaviors. Some of these resources are limited by accessibility and scalability. Remote locations and staffing limitations create challenges for parents aiming to access their child's health information. Mobile health apps offer a scalable, accessible solution for improving health literacy by enabling access to health information through mobile devices., Objective: The aim of our study is to create an inventory of acute childhood illness apps that are available to North American parents and caregivers, assess their quality, and identify the areas in which future apps can be improved., Methods: We conducted an environmental scan to identify and summarize app information for parents and digital health researchers. The Google and Apple app marketplaces were used as search platforms. We built a list of search terms and searched the platforms for apps targeted at parents and related to acute pediatric illnesses in the United States and Canada. We assessed apps meeting the inclusion criteria using the Mobile App Rating Scale (MARS), a validated tool for assessing the quality of health apps. The MARS examines apps on 5 subscales: engagement, functionality, aesthetics, information quality, and subjective quality. Data were analyzed by MARS subscale averages and individual item scores., Results: Overall, 650 unique apps were screened, and 53 (8.2%) were included. On a scale of 1-5, apps had an average engagement score of 2.82/5 (SD 0.86), functionality score of 3.98/5 (SD 0.72), aesthetics score of 3.09/5 (SD 0.87), information quality score of 2.73/5 (SD 1.32), and subjective quality score of 2.20/5 (SD 0.79). On the same scale of 1-5, app scores ranged from 2.2/5 to 4.5/5 (mean 3.2, SD 0.6). The top 3 MARS-scored apps were Baby and Child First Aid (4.5/5), Ada (4.5/5), and HANDi Paediatric (4.2/5). Taken together, the top 3 apps covered topics of emergency pediatric first aid, identification of (and appropriate response to) common childhood illnesses, a means of checking symptoms, and a means of responding to emergency situations. There was a lack of Canadian-based app content available to parents in both marketplaces; this space was filled with content originating primarily in the United Kingdom and the United States. In addition, published evidence of the impact of the included apps was poor: of 53 apps, only 5 (9%) had an evidence base showing that the app had been trialed for usability or efficacy., Conclusions: There is a need for evidence-based acute childhood illness apps of Canadian origin. This environmental scan offers a comprehensive picture of the health app landscape by examining trends in acute childhood illness apps that are readily available to parents and by identifying gaps in app design., (©James Benoit, Lisa Hartling, Michelle Chan, Shannon Scott. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 19.10.2021.)
- Published
- 2021
- Full Text
- View/download PDF
6. Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.
- Author
-
Salaun E, Mahjoub H, Dahou A, Mathieu P, Larose É, Després JP, Rodés-Cabau J, Arsenault BJ, Puri R, Clavel MA, and Pibarot P
- Subjects
- 1-Alkyl-2-acetylglycerophosphocholine Esterase blood, Aged, Bioprosthesis, Canada, Echocardiography, Doppler methods, Female, Hemodynamics, Humans, Longitudinal Studies, Male, Outcome and Process Assessment, Health Care, Proprotein Convertase 9 blood, Prospective Studies, Prosthesis Design, Prosthesis Failure, Reoperation methods, Reoperation mortality, Tomography, X-Ray Computed methods, Aortic Valve pathology, Aortic Valve physiopathology, Aortic Valve surgery, Aortic Valve Insufficiency surgery, Aortic Valve Stenosis surgery, Calcinosis blood, Calcinosis etiology, Calcinosis physiopathology, Calcinosis surgery, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis Implantation methods, Postoperative Complications blood, Postoperative Complications diagnosis, Postoperative Complications physiopathology, Postoperative Complications surgery
- Abstract
Background: Dysmetabolic profile has been associated with native aortic valve stenosis. However, there are limited data on the effects of an atherogenic milieu and its potential implications on the structural and hemodynamic deterioration of aortic bioprosthetic valves., Objectives: This prospective longitudinal study sought to determine the predictors and impact on outcomes of hemodynamic valve deterioration (HVD) of surgically implanted aortic bioprostheses., Methods: A total of 137 patients with an aortic bioprosthesis implanted for a median time of 6.7 (interquartile range: 5.1 to 9.1) years prospectively underwent a first (baseline) assessment with complete Doppler echocardiography, quantitation of bioprosthesis leaflet calcification by multidetector computed tomography (CT), and a fasting blood sample to assess cardiometabolic risk profile. All patients underwent a second (follow-up) Doppler echocardiography examination at 3 (interquartile range: 2.9 to 3.3) years post-baseline visit. HVD was defined by an annualized change in mean transprosthetic gradient ≥3 mm Hg/year and/or worsening or transprosthetic regurgitation by ≥1/3 class. The primary endpoint was a nonhierarchical composite of death from any cause or aortic reintervention procedure (redo surgical valve replacement or transcatheter valve-in-valve implantation) for bioprosthesis failure., Results: Thirty-four patients (25.6%) had leaflet calcification on baseline CT, and 18 patients (13.1%) developed an HVD between baseline and follow-up echocardiography. Fifty-two patients (38.0%) met the primary endpoint during subsequent follow-up after the second echocardiographic examination. Leaflet calcification (hazard ratio [HR]: 2.58; 95% confidence interval [CI]: 1.35 to 4.82; p = 0.005) and HVD (HR: 5.12; 95% CI: 2.57 to 9.71; p < 0.001) were independent predictors of the primary endpoint. Leaflet calcification, insulin resistance (homeostatic model assessment index ≥2.7), lipoprotein-associated phospholipase A2 activity (Lp-PLA2 per 0.1 nmol/min/ml increase), and high level of proprotein convertase subtilisin/kexin 9 (PCSK9) (≥305 ng/ml) were associated with the development of HVD after adjusting for age, sex, and time interval since aortic valve replacement., Conclusions: HVD identified by Doppler echocardiography is independently associated with a marked increase in the risk of valve reintervention or mortality in patients with a surgical aortic bioprosthesis. A dysmetabolic profile characterized by elevated plasma Lp-PLA2, PCSK9, and homeostatic model assessment index was associated with increased risk of HVD. The presence of leaflet calcification as detected by CT was a strong predictor of HVD, providing incremental risk-predictive capacity., (Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
7. Vasopressor and Inotrope Use in Canadian Emergency Departments: Evidence Based Consensus Guidelines.
- Author
-
Djogovic D, MacDonald S, Wensel A, Green R, Loubani O, Archambault P, Bordeleau S, Messenger D, Szulewski A, Davidow J, Kircher J, Gray S, Smith K, Lee J, Marc Benoit J, and Howes D
- Subjects
- Canada, Critical Care methods, Humans, Cardiotonic Agents therapeutic use, Consensus, Critical Care standards, Emergency Service, Hospital standards, Practice Guidelines as Topic standards, Shock, Cardiogenic drug therapy, Vasoconstrictor Agents therapeutic use
- Published
- 2015
- Full Text
- View/download PDF
8. [SURVIVAL AND MULTIPLICATION OF BCG AND OF THE TUBERCLE BACILLUS IN MICE. III. COMPARISON OF BRAZILIAN, CANADIAN, DANISH, FRENCH, JAPANESE AND RUSSIAN DAUGHTER STRAINS].
- Author
-
LY-THANH-DANG, BENOIT JC, PANISSET M, and FRAPPIER A
- Subjects
- Animals, Brazil, Canada, Humans, Mice, Russia, Asian People, BCG Vaccine, Bacillus, Mycobacterium bovis, Mycobacterium tuberculosis, Nuclear Family, Research, Vaccination
- Published
- 1963
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.